AMP-110

BIOLOGICAL2 trials

Sponsors

MedImmune LLC

Conditions

Rheumatoid Arthritis

Phase 1

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid Arthritis

CompletedNCT01878123

MedImmune LLCRheumatoid Arthritis

Start: 2013-04-30End: 2014-07-31Updated: 2016-09-30

Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis

CompletedNCT02277574

MedImmune LLCRheumatoid Arthritis

Start: 2014-06-30End: 2015-07-31Updated: 2016-11-21